NMPA Approval

Recombinant Human Interleukin-2（I）for Injection

Approval Number

国药准字S20053057

Company辽宁卫星生物制品研究所（有限公司）

Registration Date

June 24, 2020

Drug Information

Generic Name

注射用重组人白介素-2(Ⅰ)

Brand Name

赛迪恩

Dosage Form

注射剂

Strength

200万IU/支

Drug Type

生物制品

Registration Date

June 24, 2020

Company Information

Applicant Company

Company Name辽宁卫星生物制品研究所（有限公司）

Manufacturing Company

Company Name辽宁卫星生物制品研究所（有限公司）

Company Address

沈阳市大东区东站街51甲-3号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用重组人白介素-2(Ⅰ) - NMPA 批准文号 | MedPath